Shannon Boye, PhD ’06, an associate professor in the department of ophthalmology at UF, leads the development of a gene therapy for Leber congenital amaurosis type 1, or LCA1, a disease where children lose their vision due to a genetic mutation that inhibits protein production in the eye’s rod and cone photoreceptors. Upon graduating from the UF College of Medicine, Boye completed a postdoctoral fellowship in the lab of UF ophthalmology professor William Hauswirth, PhD.
“The next big breakthrough in medicine is happening right now thanks to gene therapy, and UF is ground zero. We are a leader in the field and we’re getting these therapies to patients. I feel incredibly fortunate that I’ve been able to be in this field at a time when things officially started to transition from the bench to the bedside.”